TY - JOUR
T1 - Effectiveness of scapular mobilization in patients with primary adhesive capsulitis
T2 - A systematic review and meta-analysis
AU - Olguín-Huerta, Cristian
AU - Araya-Quintanilla, Felipe
AU - Moncada-Ramírez, Victoria
AU - Estrella-Flores, Evelin
AU - Cuyúl-Vásquez, Iván
AU - Gutiérrez-Espinoza, Héctor
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/6/2
Y1 - 2023/6/2
N2 - Background: The aim of this study was to determine the effectiveness of scapular mobilization on range of motion, shoulder disability, and pain intensity in patients with primary adhesive capsulitis (AC). Methods: An electronic search was performed in the MEDLINE, EMBASE, SCOPUS, CENTRAL, LILACS, CINAHL, SPORTDiscus, and Web of Science databases up to March 2023. The eligibility criteria for selected studies included randomized clinical trials that included scapular mobilization with or without other therapeutic interventions for range of motion, shoulder disability, and pain intensity in patients older than 18 years with primary AC. Two authors independently performed the search, study selection, and data extraction, and assessed the risk of bias using the Cochrane Risk of Bias 2 tool. Results: Six randomized clinical trials met the eligibility criteria. For scapular mobilization versus other therapeutic interventions, there was no significant difference in the effect sizes between groups: the standard mean difference was -0.16 (95% confidence interval [CI] = -0.87 to 0.56; P =.66) for external rotation, -1.01 (95% CI = -2.33 to 0.31; P =.13) for flexion, -0.29 (95% CI = -1.17 to 0.60; P =.52) for shoulder disability, and 0.65 (95% CI = -0.42 to 1.72; P =.23) for pain intensity. Conclusions: Scapular mobilization with or without other therapeutic interventions does not provide a significant clinical benefit regarding active shoulder range of motion, disability, or pain intensity in patients with primary AC, compared with other manual therapy techniques or other treatments; the quality of evidence was very low to moderate according to the grading of recommendation, assessment, development and evaluation approach.
AB - Background: The aim of this study was to determine the effectiveness of scapular mobilization on range of motion, shoulder disability, and pain intensity in patients with primary adhesive capsulitis (AC). Methods: An electronic search was performed in the MEDLINE, EMBASE, SCOPUS, CENTRAL, LILACS, CINAHL, SPORTDiscus, and Web of Science databases up to March 2023. The eligibility criteria for selected studies included randomized clinical trials that included scapular mobilization with or without other therapeutic interventions for range of motion, shoulder disability, and pain intensity in patients older than 18 years with primary AC. Two authors independently performed the search, study selection, and data extraction, and assessed the risk of bias using the Cochrane Risk of Bias 2 tool. Results: Six randomized clinical trials met the eligibility criteria. For scapular mobilization versus other therapeutic interventions, there was no significant difference in the effect sizes between groups: the standard mean difference was -0.16 (95% confidence interval [CI] = -0.87 to 0.56; P =.66) for external rotation, -1.01 (95% CI = -2.33 to 0.31; P =.13) for flexion, -0.29 (95% CI = -1.17 to 0.60; P =.52) for shoulder disability, and 0.65 (95% CI = -0.42 to 1.72; P =.23) for pain intensity. Conclusions: Scapular mobilization with or without other therapeutic interventions does not provide a significant clinical benefit regarding active shoulder range of motion, disability, or pain intensity in patients with primary AC, compared with other manual therapy techniques or other treatments; the quality of evidence was very low to moderate according to the grading of recommendation, assessment, development and evaluation approach.
KW - adhesive capsulitis
KW - frozen shoulder
KW - meta-analysis
KW - musculoskeletal manipulations
KW - range of motion
KW - scapular mobilization
UR - http://www.scopus.com/inward/record.url?scp=85160967798&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000033929
DO - 10.1097/MD.0000000000033929
M3 - Article
C2 - 37266649
AN - SCOPUS:85160967798
SN - 0025-7974
VL - 102
SP - E33929
JO - Medicine (United States)
JF - Medicine (United States)
IS - 22
ER -